002898 Share Price Performance
CN¥11.75
2.96 (33.67%)
Price CN¥11.75
Share Pricen/a
Sailong Pharmaceutical Group Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
002898 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Sailong Pharmaceutical Group Co.,Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 27, 2026
- -0.40
- 12.51%
- -28.53%
- 24.5%
About 002898
- Founded
- 2002
- Employees
- 514
- CEO
- WebsiteView website
Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pantoprazole sodium products, etc. It provides its products for therapeutic areas, such as cardiovascular, cerebrovascular, nerve, digestive system, proton pump inhibitors, anti-infectives, anti-bleeding drugs, analgesics, and other fields. Sailong Pharmaceutical Group Co.,Ltd. was formerly known as Zhuhai Sailong Pharmaceutical Co.,Ltd. and changed its name to Sailong Pharmaceutical Group Co.,Ltd. in September 2021. The company was founded in 2002 and is based in Zhuhai, China.
